SIRT6 Promotes DNA Repair Under Stress by Activating PARP1

See allHide authors and affiliations

Science  17 Jun 2011:
Vol. 332, Issue 6036, pp. 1443-1446
DOI: 10.1126/science.1202723


Sirtuin 6 (SIRT6) is a mammalian homolog of the yeast Sir2 deacetylase. Mice deficient for SIRT6 exhibit genome instability. Here, we show that in mammalian cells subjected to oxidative stress SIRT6 is recruited to the sites of DNA double-strand breaks (DSBs) and stimulates DSB repair, through both nonhomologous end joining and homologous recombination. Our results indicate that SIRT6 physically associates with poly[adenosine diphosphate (ADP)–ribose] polymerase 1 (PARP1) and mono-ADP-ribosylates PARP1 on lysine residue 521, thereby stimulating PARP1 poly-ADP-ribosylase activity and enhancing DSB repair under oxidative stress.

Mammalian sirtuin (SIRT) proteins function in multiple pathways, including stress response and genome maintenance (13). SIRT1- and SIRT6-deficient cells have a reduced ability to repair double-strand breaks (DSBs) (4, 5), and SIRT6 knockout mice exhibit a premature aging phenotype associated with impaired base excision repair (BER) (6). Furthermore, SIRT6 participates in homologous recombination (HR) by deacetylating C-terminal binding protein (CtBP) interacting protein (CtIP) (7). Repair of DNA DSBs is essential for longevity, and mutations in DSB repair genes lead to premature aging phenotypes (8). Due to the involvement of sirtuins in stress response and DNA repair, we hypothesized that members of the Sir2 family may promote longevity by integrating stress signaling and DNA DSBs repair pathways.

To examine the ability of SIRT proteins to promote DSB repair under stress, we used two diploid human fibroblast cell lines containing chromosomally integrated green fluorescent protein–based reporter constructs (9), which allow for the separate analysis of HR and nonhomologous end joining (NHEJ) (fig. S1). We overexpressed the four nuclear-localized human sirtuins (SIRT1, SIRT2, SIRT6, or SIRT7) in the reporter cell lines (Fig. 1A) and measured the efficiency of DSB repair. Overexpression of SIRT1 and SIRT2 had no effect on DSB repair, whereas overexpression of SIRT6 improved the efficiency of NHEJ by 3.3-fold and HR by 3.4-fold (Fig. 1B). SIRT7 overexpression increased the efficiency of NHEJ by 1.5-fold and HR by 2.8-fold (Fig. 1B). We pretreated the cells with paraquat before induction of DSBs to test the effect of oxidative stress in the DNA repair assay. Only SIRT6 overexpression under stress led to a significant stimulation of NHEJ by 6.7-fold and HR by 6-fold relative to control paraquat-treated cells or 16-fold relative to untreated controls (Fig. 1B). Addition of a sirtuin inhibitor, nicotinamide, which inhibits both deacetylase and mono–adenosine diphosphate (ADP)–ribosylase activities, abolished the stimulatory effect of SIRT6 overexpression (Fig. 1B). We also observed stimulation of DSB repair by SIRT6 when a different inducer of oxidative stress, H2O2 was used (fig. S2). Furthermore, overexpression of SIRT6 accelerated clearance of γH2AX foci in paraquat treated cells (Fig. 1C) and accelerated repair of DSBs induced by neocarzinostatin, measured by a neutral comet assay (fig. S3). Additional experiments demonstrating the stimulatory effect of SIRT6 on DSB repair are shown in fig. S4. Oxidative stress elevated endogenous SIRT6 levels (Fig. 1D), indicating that ectopic overexpression enhances this physiological response. We also showed that depletion of SIRT6 compromises DSB repair, especially under stress (fig. S5). Together, these observations suggest that SIRT6 plays an important regulatory role in the DNA damage response by stimulating DSB repair under oxidative stress.

Fig. 1

SIRT6 stimulates DSB repair. (A) Overexpression of SIRT1, -2, -6, and -7 in human fibroblasts. Immunoblotting with sirtuin-specific antibodies after transfection with a sirtuin-expressing vector or a control vector encoding hypoxanthine-guanine phosphoribosyltransferase (pControl). (B) Effect of sirtuin overexpression on the efficiency of NHEJ and HR, measured as described in (27) and fig. S1. The efficiency of DSB repair was scored in untreated cells (open bars), cells pretreated with 1 mM paraquat for 16 hours (black bars), or cells treated with paraquat and 5 mM nicotinamide for 16 hours (red bars). Error bars indicate SD; n = 8 experiments (control and SIRT6); n = 3 (other sirtuins). P values were calculated by two-tailed Student’s t test. GFP, green fluorescent protein. (C) SIRT6 overexpression accelerates the disappearance of γH2AX foci after treatment with 1 mM paraquat for 16 hours. Data represents an average of at least 50 nuclei. Error bars indicate SEM. (D) Immunoblot showing induction of endogenous SIRT6 protein levels by oxidative stress. Human fibroblasts were treated with paraquat for 16 hours.

SIRT6 is a chromatin-associated protein (6, 10) that binds to sites of DNA DSBs (5). SIRT6 distribution in untreated cells showed distinct aggregates within the nucleus that colocalized with heterochromatin protein HP1β (fig. S6). Next, we used chromatin immunoprecipitation (ChIP) to analyze SIRT6 recruitment to damaged DNA after oxidative stress. SIRT6 was recruited to Alu elements after γ-irradiation (Fig. 2A) and to the site-specific DSB generated by I-SceI (Fig. 2B and fig. S7). In the absence of oxidative stress, SIRT6 was recruited after 8 and 10 hours of γ-irradiation and I-SceI transfection, respectively. When the cells were pretreated with paraquat, we observed an additional, early wave of SIRT6 recruitment, within 30 min after induction of DSBs. Thus, under normal conditions SIRT6 is recruited to DSBs relatively late, whereas preexisting oxidative stress results in early mobilization of SIRT6.

Fig. 2

Oxidative stress results in early recruitment of SIRT6 to DNA breaks. ChIP analysis showing kinetics of SIRT6 recruitment to Alu sequences after 8 Gy of γ-irradiation (IR) (A) and sequences flanking I-SceI–induced DSB after transfection with I-SceI expression vector (B). Asterisks indicate values significantly different from corresponding zero time points (P < 0.05). Error bars indicate SD; n = 5. Control ChIP with SIRT6−/− cells is shown in fig. S7. IgG, immunoglobulin G.

Sir2 family members have two enzymatic activities, deacetylase and mono-ADP-ribosyltransferase (1113). To determine which enzymatic activity is important for the stimulation of DSB repair, we introduced point mutations in conserved residues of SIRT6: Ser56→Tyr56 (S56Y) (14) lacks both deacetylase and mono-ADP-ribosyltransferase activities, G60A lacks mono-ADP-ribosyltransferase activity, and R65A lacks deacetylase activity (Fig. 3, A and B). All three mutations reduced the ability of SIRT6 to stimulate DSB repair, suggesting that both activities are important for this function (Fig. 3C).

Fig. 3

Deacetylation and mono-ADP-ribosylation activities of SIRT6 are required to stimulate DSB repair. (A) Immunoblot showing that S56Y and R65A mutations abolish the H3K9 deacetylation activity of Sirt6 and appear to exert a dominant-negative effect. (B) In vitro assay showing that S56Y and G60A mutations abolish mono-ADP-ribosylation activity of SIRT6. NAD+, nicotinamide adenine dinucleotide. (C) SIRT6 mutants for deacetylation and/or ribosylation activities have reduced ability to stimulate NHEJ and HR. Untreated cells (open bars) or cells treated with paraquat (black bars) were transfected with SIRT6-expressing vectors or pControl. Error bars indicate SD; n = 4.

To identify the substrate of SIRT6 mono-ADP-ribosylation, we introduced biotin-labeled nicotinamide adenine dinucleotide (NAD), a substrate for mono-ADP-ribosyltransferase, into wild-type (WT) and SIRT6−/− mouse embryo fibroblasts (MEFs), which were pretreated with paraquat. Poly-ADP-ribosylated proteins were depleted from the cell extracts using poly-ADP-ribose antibodies. The remaining mono-ADP-ribosylated proteins were isolated using avidin-coated beads. We observed two bands corresponding to proteins of approximately 120 and 70 kD (Fig. 4A). The 120-kD band was present at higher levels in the WT than in the SIRT6−/− cells, suggesting that ribosylation of this protein is mediated by SIRT6. The level of the 70-kD band was independent of the SIRT6 status. We focused on the 120-kD protein hypothesizing that the band corresponded to poly(ADP-ribose) polymerase 1 (PARP1). This was confirmed by Western blotting with PARP1 antibodies (Fig. 4B). Coimmunoprecipitation showed that SIRT6 physically associates with PARP1, and the interaction between SIRT6 and PARP1 was resistant to the addition of ethidium bromide (Fig. 4C), indicating that the two proteins interact directly rather than through binding to DNA. The molecular weight of PARP1 immunoprecipitated with SIRT6 is higher than of the input PARP1, suggesting that PARP1 bound by SIRT6 was mono-ADP-ribosylated (Fig. 4C). The amount of SIRT6-PARP1 complexes increased after DNA damage (fig. S8).

Fig. 4

SIRT6 interacts with PARP1 and stimulates its poly-ADP-ribosylation activity. (A) Analysis of mono-ADP-ribosylated proteins in the WT and SIRT6−/− MEFs stressed with paraquat for 16 hours. Cells were transfected with biotinylated NAD, and poly-ADP-ribosylated proteins were cleared away with PAR antibodies. Immunoprecipitation (IP) of the mono-ADP-ribosylated proteins revealed bands of 120 and 70 kD. KO, knockout; WB, Western blot. (B) Immunoblotting of the extracts in (A) with PARP1 antibodies indicated that the 120-kD band is Parp1. (C) SIRT6 interacts with PARP1. Human fibroblasts were treated with 1 mM paraquat. Cell lysates were immunoprecipitated with SIRT6 antibodies in the presence of 50 μg/ml ethidium bromide (EtBr) followed by Western blotting with PARP1 antibodies. (D) PARP1 K521 is essential for activation of NHEJ by SIRT6. An NHEJ assay was performed in PARP1−/− MEFs containing an integrated NHEJ reporter. Cells were transfected with SIRT6 and/or PARP1 or PARP1 mutants. Both SIRT6 and PARP1 are required for the stimulation of repair. PARP1 Y889C is a catalytically inactive PARP1. PARP1 DEEKKK contains mutations in all six poly-ADP-ribosylation sites. PARP1 DEEKK contains the same mutations, except at K521. Error bars show SD; asterisks indicate values significantly different from control (P < 0.01). (E) PARP1 lacking the catalytic domain is mono-ADP-ribosylated by SIRT6 in vitro, whereas K521A is not. (F) In vitro assay of PARP1 poly-ADP-ribosylation activity showing that PARP1 is stimulated only by SIRT6 mono-ADP-ribosylation activity. The graph shows quantification of six independent experiments. Error bars show SD; asterisks indicate values significantly different from control (P < 0.01). (G) Stimulation of NHEJ and HR by SIRT6 is abolished by PARP1 inhibitors 3-ABA (5 mM) or PJ34 (20 μM). Error bars indicate SD; n = 4.

We introduced mutations into the six known PARP1 ribosylation sites (15, 16)—D387A, E488A, E491A, K498A, K521A, and K524A—and used PARP1 knockout mouse fibroblasts containing integrated NHEJ reporter to test whether these mutants can mediate the effect of SIRT6 on repair. SIRT6 overexpression did not stimulate NHEJ in PARP1 knockout cells (Fig. 4D). However, when SIRT6 was cotransfected with the WT PARP1, but not with catalytically inactive PARP1 Y889C, it led to stimulation of NHEJ, indicating that PARP1 is required to mediate the effect of SIRT6 on repair. The PARP1 K521A mutant was sufficient to abolish the stimulation of repair by SIRT6, whereas the mutations in the other five ribosylation sites had no effect, either alone or in combination (Fig. 4D), indicating that SIRT6 ribosylates PARP1 on K521. This was confirmed by showing that purified PARP1 was mono-ADP-ribosylated by SIRT6, whereas K521A mutant was not (Fig. 4E). Neither was K521A modified by SIRT6 in vivo (fig. S9).

PARP1 binds to DNA damage sites and activates itself by automodification. It also poly-ADP-ribosylates other proteins around DNA damage sites facilitating recruitment of DNA repair factors (1719). To test whether PARP1 activation is enhanced by mono-ADP-ribosylation by SIRT6, we analyzed PARP1 activity in vitro in the presence of SIRT6. WT SIRT6 protein and the R65A mutant, which has only mono-ADP-ribosylation activity, strongly stimulated PARP1 (Fig. 4F). The SIRT6 G60A mutant, which has only deacetylation activity, failed to stimulate PARP1, whereas the enzymatically inactive S56Y mutant was inhibitory (Fig. 4F). We did not detect changes in PARP1 acetylation status after incubation with SIRT6 (fig. S10). To test the effect of SIRT6 on PARP1 activity in vivo, we transfected human fibroblasts with the WT SIRT6 and SIRT6 mutants. WT SIRT6 and the R65A mutant enhanced PARP1 poly-ADP-ribosylation, whereas S56Y and G60A mutants failed to stimulate PARP1 (fig. S11). Furthermore, PARP1 inhibitors 3-ABA and PJ34 suppressed SIRT6-mediated activation of NHEJ and HR (Fig. 4G). From this result, we conclude that SIRT6 promotes DSB repair by stimulating PARP1.

Multiple lines of evidence (20, 21) support the role of PARP1 in DSB repair and in suppressing aberrant recombination events by stabilizing broken DNA ends (22, 23). Furthermore, PARP1 is required for an alternative, DNA–dependent protein kinase catalytic subunit (PKcs) independent pathway of NHEJ (24, 25). Overexpression of SIRT6 in DNA-PKcs null MEFs up-regulated NHEJ by 1.7-fold, and in the WT MEFs by 2.3-fold (fig. S12), suggesting that SIRT6 stimulates the alternative NHEJ pathway.

In this study, we identify PARP1 as the in vivo target of SIRT6 ribosylation. As PARP1 is involved in both BER and DSB repair (17, 26), the role of SIRT6 as an activator of PARP1 explains the phenotype of the SIRT6 knockout mice, which are characterized by deficient BER and genomic instability probably stemming from a defect in DSB repair (6). In the absence of oxidative stress, SIRT6 overexpression mildly induced repair, whereas under stress DNA repair was stimulated up to 16-fold. This observation suggests that SIRT6 plays a regulatory function in DNA repair by integrating DNA repair and stress signaling pathways.

Supporting Online Material

Materials and Methods

SOM Text

Figs. S1 to S12


References and Notes

  1. Single-letter abbreviations for the amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.
  2. Materials and methods are available as supporting material on Science Online.
  3. Acknowledgments: This work was supported by grants from the NIH (to V.G.) and the Ellison Medical Foundation (to V.G. and A.S.). Z.M. performed DNA repair assays, immunoblots, coimmunoprecipitations, in situ staining, and biochemical assays; C.H. and A.V. performed ChIP; X.T. analyzed PARP1 mutants; M.V.M. analyzed DNA damage foci; M.A. performed comet assays; and Z.M., C.H., A.S., and V.G. designed the study, analyzed data, and wrote the manuscript.
View Abstract

Navigate This Article